RESULTS: Among the 196 cases enrolled, 152 were confirmed as pN0, 36 as pN1, 6 as pN1 + N2 and 2 as skip pN2. When the LSNs had not been dissected, the false-negative rate for N staging was 9.0% (15 of 167). Patients with adjacent LSN metastasis (P < 0.001), solid nodule (P = 0.001), non-lepidic predominant invasive adenocarcinoma (P < 0.001), nodules with maximum diameter larger than 2 cm (P < 0.001) and those with elevated serum carcinoembryonic antigen level (>5 ng/ml) (P = 0.005) had a higher isolated LSN metastasis rate. No significant difference in isolated LSN metastasis rate was found between groups with or without smoking history (P = 0.90) and with different serum Cyfra21-1 levels (P = 0.14).
INTRODUCTION
For cT1N0M0 stage lung adenocarcinoma, whether segmentectomy is inferior to lobectomy in terms of local control and prognosis is still controversial; 2 of the largest international clinical trials (CALGB 140503 and JCOG0802/WJOG4607L) are still inconclusive [1, 2] . It is now widely accepted that for tumours less than 2 cm, especially for pure ground-glass nodules (GGNs), segmentectomy can be used [3] [4] [5] [6] . However, the resection range should not only depend on the size of the tumour (T stage), distance between the resection margin and tumour border. Lymphatic metastasis status (N stage), especially local lymphatic metastasis status, might be another definitive factor for the resection range.
Lymphatic metastasis is the major and most common route of metastasis for non-small-cell lung cancer (NSCLC) as well as an important factor affecting clinical staging and prognosis. Considering the lymphatic drainage hypothesis, the premise for segmentectomy should at least include the least possibility of lymph node metastasis in the residual segments within the same lobe. However, the existing pathological examination in many areas cannot guarantee sufficient collection of lobar and segmental lymph nodes (LSNs) from the resected specimens, which include the residual lymph node Station 12 and nodal Stations 13 and 14 in the specimen. Thus, segmentectomy with uncertain LSNs metastatic status remains a potential oncological risk.
We performed a single-centre prospective study, aiming to clarify the regularity of LSN metastasis in cT1N0M0 lung adenocarcinoma. LSNs from 196 cases of cT1N0M0 stage lung adenocarcinoma were dissected and sorted carefully by thoracic surgeons after lobectomy. More accurate postoperative diagnosis and staging were achieved. In addition, we managed to filter more suitable cases for segmentectomy from the perspective of lymphatic drainage by analysing patterns of LSN metastasis considering the size of the lesions, imaging features, serum tumour markers and the pathological subtypes.
MATERIALS AND METHODS

Clinical data
A total of 250 cases of cT1N0M0 stage NSCLC were diagnosed in the Thoracic Surgery Department of China-Japan Friendship Hospital from March 2014 to September 2016 (Fig. 1) . All patients were confirmed not to have distant metastases using cerebral magnetic resonance imaging/computed tomography (CT), chest and abdominal CT, bone scintigraphy or positron emission tomography CT. Five patients did not consent to participate in the study. A pathological diagnosis was obtained by preoperative CT-guided biopsy or intraoperative fast-frozen pathology. Anatomical lobectomy and mediastinal lymph node dissection were then carried out. Thirty-eight nonadenocarcinoma cases were excluded. Six cases of right middle lobe adenocarcinoma were excluded considering the specific anatomical features of the right middle lobe, as they were unsuitable for intentional segmentectomy. Five cases of suspected multiple primary lung adenocarcinomas were excluded considering the interaction between multiple primary lung cancers according to the 'field cancerization' theory [7] . The remaining 196 cases of cT1N0M0 stage lung adenocarcinoma were enrolled in the study.
Tumour resection and lobar and segmental lymph nodes dissection
A total of 196 complete video-assisted thoracoscopic surgery or video-assisted thoracoscopic surgery-assisted lobectomies were performed. Routine systemic lymph node dissection was applied to all cases according to the lymph node map [8] in the seventh edition of TNM staging of lung cancer issued by the International Association for the Study of Lung Cancer (IASLC). Mediastinal lymph node Stations 2R, 4R, 3a, 7 and 9; nodal Stations 10 and 11; and part of lymph node Station 12 were dissected on the right. Mediastinal lymph node Stations 4l, 5, 6, 7 and 9; nodal Stations 10 and 11; and part of lymph node Station 12 were dissected on the left. Immediately after the procedure, a specified thoracic surgeon was there to dissect the specimen along the bronchial tree, LSNs including the residual lymph node Station 12 along the lobar bronchus, lymph node Station 13 along the segmental bronchus and lymph node Station 14 along the subsegmental bronchus were dissected and sorted carefully. According to Matsumura et al.'s [9] classification of LSNs and referring to the anatomical relationship with the area of involved segmental bronchus, the lymph nodes located proximal to the involved segmental bronchus were defined as adjacent LSNs (aLSNs). These aLSNs could be dissected along the segmental bronchus on the back table after lobectomy. The lymph nodes located isolated from the involved segmental bronchus were defined as isolated LSNs (iLSNs), which could be technically challenging to resect during segmentectomy. Gross specimens along with the aLSNs, iLSNs and other lymph node stations were then sent for pathological examination. The predominant pathological subtype of every adenocarcinoma and metastatic status to each lymph node station would be concluded.
This prospective study was performed after approval by the ethics committee of China-Japan Friendship Hospital, and written consent was given by the patients for their information to be stored in the hospital database and used for clinical research.
Statistical analysis
pN staging of 196 cases of cT1N0M0 stage lung adenocarcinoma underwent statistical analysis. Changes in pN staging due to complete dissection of LSNs were investigated. Pearson's v 2 tests with continuity correction were used to perform a test of independence on iLSN metastatic status among the different groups classified by imaging features (pure/part-solid GGN and solid nodule), smoking history (with or without), serum carcinoembryonic antigen levels (>5 ng/ml or not), serum Cyfra21-1 levels (>3.3 ng/ml or not), pathological subtypes (atypical adenomatous hyperplasia, adenocarcinoma in situ, minimally invasive adenocarcinoma, lepidic predominant invasive adenocarcinoma and others), maximum diameter of lesion on imaging (< _2 cm or not) and aLSN metastasis status (with or without aLSN metastasis). SPSS19.0 software (IBM SPSS Statistics for Windows, IBM Corp., Version 19.0, Armonk, NY, USA) was used for statistical analysis and significance was defined as P-value <0.05.
RESULTS
Clinical and pathological results
Gender, age, smoking history, size and location of the lesions, preoperative serum level of tumour markers (carcinoembryonic antigen and Cyfra21-1) and imaging characteristics of all 196 enrolled cases are presented in Table 1 .
All of the cases underwent T and N restaging after the pathological result was confirmed, including the detailed pathological subtypes according to the new adenocarcinoma classification standard [10] , as presented in Table 2 . 
Analysis of false-negative results for N staging
All dissected lymph nodes and LSNs in the 196 specimens after the lobectomy were classified and subjected to pathologic examination. A total of 152 cases of pN0, 36 cases of pN1 and 8 cases of pN2 were confirmed. Detailed pN staging is illustrated in Fig. 2 . Among the 36 pN1 cases, 28 cases were found with LSN metastasis and 15 cases were found with metastasis to the LSN only. Except for 2 cases of skip N2 metastasis, the other 6 N2 cases were identified with metastasis to both the N1 and N2 stations. Among the 6 cases of pN1 + N2, 4 cases were found with LSN metastasis and 2 of them were found with metastasis to LSN and N2 only. If LSNs were not dissected and sorted carefully, 15 cases of N1 cases would be misdiagnosed as N0, while 2 cases of N1 + N2 cases would be misdiagnosed as skip N2.
Assuming a false lymphatic metastasis status if LSNs were not pathologically examined, the comparative result to actual lymphatic metastasis status is presented in Table 3 . Without examination of the LSNs, 15 of the 167 cases would have been misdiagnosed as pN0 and the false-negative rate for N staging would be as high as 9.0%.
Analysis of metastasis to the adjacent and isolated lobar and segmental lymph node Upon detailed analysis of the 28 pN1 cases and 4 pN2 cases with LSNs metastases, 30 cases were found with lymph node metastasis located proximal to the involved segmental bronchus, also known as aLSN metastasis, while 12 of them (40.0%) were found with iLSN metastasis at the same time. Only 2 cases were found with iLSN metastasis alone. The first one was a 52-year-old woman and the solid nodule was located on S6 of the right lower lobe with a maximum diameter of 2.2 cm on chest CT, and preoperative serum level of CEA was 4.68 ng/ml. The second one was a 66-year-old woman and the part-solid nodule was located on S2 of the right upper lobe with a maximum diameter of 1.4 cm on chest CT, and preoperative serum level of CEA was 6.12 ng/ml. Both lesions were confirmed as papillary predominant invasive adenocarcinoma by pathological examination. In the first case, iLSN metastasis was found in the basal segment of the right lower lobe, while in the second case, iLSN metastasis was found on the anterior wall of the right upper lobar bronchus. In Table 4 , we compared the iLSN metastasis rate between groups. The pure and part-solid GGNs group had a lower iLSN metastasis rate compared with the solid nodule group with a significant statistical difference (P = 0.001). The non-lepidic predominant invasive adenocarcinoma group (P < 0.001), cT1b (seventh TNM staging) group (P < 0.001) and those with aLSN metastasis (P < 0.001) were detected with a higher iLSN metastasis rate. Increased serum CEA level (>5 ng/ml) could lead to higher probability of iLSN metastasis (P = 0.005), while smoking history (P = 0.90) and serum Cyfra21-1 level (P = 0.14) cannot be an independent risk factor to predict the metastatic probability of iLSN.
DISCUSSION
For peripheral lung adenocarcinoma, lymphatic drainage always proceeds from near to distant, from intrapulmonary to mediastinal through the hilum [11] . As the lymph node Stations 12, 13 and 14 are close to the tumour, the LSNs could be affected in the very early stage and become the initial station for metastasis. Accurate pathologic nodal staging mandates effective collaboration between surgeons and pathologists. LSNs should be routinely examined after lobectomy, as insufficient pathological examination might lead to false-negative result of lymph node metastasis and have an adverse impact on tumour staging, adjuvant treatment options and prognosis [12] .
Naruke et al. [13] were the first to report a nodal Station 13 metastasis rate of 8.4-17.6% and the nodal Station 14 metastasis rate of 2.5-4.7% in large samples of NSCLCs. In our study, 152 of the 196 cases with cT1N0M0 stage lung adenocarcinoma were diagnosed as pN0, making the detection rate of lymph node metastasis as high as 22.4% (44 of 196), higher than the average rate of 11-13% in cT1N0M0 stage NSCLC lymph node metastasis as reported in the literature [9, 14, 15] . This might be because of the higher lymph node metastasis rate of lung adenocarcinoma, a large proportion of nodules with maximum diameter larger than 2 cm in the enrolled cases and the relatively high ratio of pT2 cases. More importantly, the false-negative rate of N staging would be as high as 9.0%, this further indicates the importance of dissecting LSNs to help improve the accuracy of N staging and provide a basis for the optimal surgical procedure, reasonable postoperative adjuvant treatment and improvement in prognosis.
As a type of radical resection, segmentectomy has equivalent rates of perioperative morbidity, recurrence and survival with greater preservation of lung function and exercise capacity compared with lobectomy in selected patients [4] . It is now generally accepted that segmentectomy is a safe option and provides comparable oncologic results to lobectomy for small (< _2 cm) peripheral Stage IA NSCLC [3] . Other indications include the target tumour located <2 cm deep from the lung surface [16] , without hilar or mediastinal lymph node metastasis proved by fast-frozen pathology [17] , and in special cases like synchronous multiple lung nodules, or elderly patients with limited cardiopulmonary function (forced expiratory volume in 1 s <50%) or accompanied by other serious complications.
However, the aforementioned criteria do not consider the metastatic status of intrapulmonary LSNs. Considering the route of the lymphatic drainage, the premise for anatomic pulmonary segmentectomy should at least include the least possibility of lymph node metastasis in the unaffected segment within the same lobe. The sorting of LSNs would be of great importance then, because it might provide a novel perspective to evaluate the safety of segmentectomy. Besides mediastinal and hilar lymph node metastasis, metastasis to the iLSN should be another contraindication for segmentectomy.
The pathological regularity of intrapulmonary LSN metastasis in cT1N0M0 stage lung adenocarcinoma has not yet been clarified and whether LSNs in the non-resected segments should be dissected during segmentectomy is unclear [9] . iLSN sampling is restricted to anatomic position and it may lead injury to the retained segmental bronchi, arterio-venous branches or lung parenchyma, in which case extremely skilled surgical techniques are required. For example, the dissection of segmental lymph node Station 13 in the anterior segment is technically demanding during posterior segmentectomy of the right upper lobe, let alone the dissection of lymph node Station 12 along the bronchus next to the anterior segment (Fig. 3) .
On this occasion, we aim to predict the probability of iLSN metastasis to filter more suitable cases for segmentectomy, by identifying the correlation between potential risk factors and the iLSN metastatic probability.
In our study, 40.0% (12 of 30) of the cases with aLSN metastasis were found to have iLSN metastasis; when metastasis to the aLSN is proved by fast-frozen pathology, there is a higher probability of metastasis to the iLSN (P < 0.001). This indicates that segmentectomy might not be suitable for those with aLSN metastasis. This conclusion provides a novel perspective to evaluate whether segmentectomy will be sufficient. Although sampling aLSNs has not been included in the existing technical protocol, as sampling aLSNs along the segmental bronchus on the back table would not cost much time and effort, it would be more reasonable to identify the metastatic status of aLSN by frozen pathology as a supplement and then decide whether to switch to lobectomy.
According to the new adenocarcinoma classification standard [10] , lung adenocarcinoma is divided into different subtypes. The most common imaging finding on chest CT for adenocarcinoma in situ and minimally invasive adenocarcinoma is pure GGN. An extremely good prognosis with a nearly 100% disease-free survival can be expected when a pure GGN is completely resected [18, 19] . Inoue et al. [15] performed a retrospective observational study involving 118 patients who had received a complete resection for cT1N0M0 NSCLC with a solid component of more than 50% on CT, and after careful dissection and pathological examination, lymph node involvement was found in only 15 patients with a pure solid lesion. These findings indicated that mixed GGN, especially pure GGN, might be suitable for segmentectomy. Our results are consistent with prior results and suggest that pure or part-solid GGN might be suitable for segmentectomy when meeting other indications. Solid nodule (P = 0.001) or non-lepidic predominant invasive adenocarcinoma (P < 0.001) has a higher iLSN metastasis rate and might not be suitable for segmentectomy.
Despite the controversy, the mainstream opinion is that a maximum diameter of tumour <2 cm is one of the indications for segmentectomy [5, 20, 21] . Yamanaka et al. [22] performed pathologic investigations of segmental lymph node metastases for 94 small peripheral lung cancers (< _3 cm in diameter) and only 1 case with iLSN metastasis was found in 40 cases with a maximum diameter of the lesions <2 cm. For lung adenocarcinoma with a maximum diameter between 2 and 3 cm, although Asamura et al. [23] reported that the 5-year survival rate after surgery for those non-solid cases was 96.4%, the iLSN metastasis rate was significantly higher than those <2 cm cases (P < 0.001) in our study. Therefore, we believe a maximum diameter larger than 2 cm is a contraindication for segmentectomy and one should be on the alert for the possibility of iLSN metastasis.
Several studies have reported that preoperative serum tumour marker level could be independent risk factors for the prognosis of cT1N0M0 stage NSCLC and have provided guidance for selection of procedures [24, 25] . Our study identified serum CEA level as a predictive value for the probability of iLSN metastasis (P = 0.005), indicating that segmentectomy might not be suitable for those cases with elevated serum CEA level. Although we failed to find a statistical difference on the probability of iLSN metastasis between groups with different serum Cyfra21-1 levels (P = 0.14), there seems to be a trend that a higher level of preoperative serum Cyfra21-1 indicates a higher rate for iLSN metastasis. Taking into consideration that smoking status may affect serum tumour marker levels and have an impact on lymph nodes metastasis [26] , our preliminary result showed no difference in iLSNs metastatic probability between patients with and without a smoking history (P = 0.90). This negative result might be due to the limited number of cases and a superficial grouping method.
Limitations
The limitations of this research include its case-series nature. Because of the limited number of cases in this single-centre prospective study, only 44 cases of non-pN0 early-stage lung adenocarcinoma were enrolled and even fewer with iLSN metastasis were enrolled. Moreover, all of the subjects were patients undergoing intentional lobectomy, indicating a potential selection bias. Therefore, larger sample size, multicentre prospective studies are still needed to confirm our results and to further determine the independent risk factors of iLSN metastasis.
Finally, it is important to emphasize that although the premise of segmentectomy should at least include the least possibility of metastasis to the iLSNs, it alone cannot be an indication for segmentectomy. Lymphatic metastasis through the visceral pleura and skip pN2 metastasis have been discovered occasionally in small non-small-cell lung carcinomas [27, 28] . Our study also identified 2 cases of skip pN2 metastasis, and these cases are clearly not suitable for segmentectomy. Therefore, all factors including tumour location, size, imaging characteristics, pathological subtypes and serum tumour marker (carcinoembryonic antigen) level need to be analysed before and during surgery.
CONCLUSION
In conclusion, our preliminary work again identified the importance of dissecting LSNs and provided a novel perspective to evaluate the safety for segmentectomy. We found that solid nodule, non-lepidic predominant invasive adenocarcinoma, lung adenocarcinoma >2 cm in maximum diameter or with elevated serum CEA levels might lead to higher probability of iLSNs metastasis and thus might not be suitable for segmentectomy. aLSNs should be sampled together with the mediastinal (N2) and hilar (N1) lymph nodes during segmentectomy, and frozen pathological result would determine whether to switch to lobectomy. Further studies with larger sample size from multicentre studies would be needed. 
